1. Javitt JC, et al. Cataract and latitude. Doc Ophthalmol 1994-95;88(3-4):307-25.
2. Ariturk N, et al. Secondary glaucoma after congenital cataract surgery. Int Ophthalmol 1998-99;22(3):175-80.
3. Spierer A, et al. Secondary glaucoma after congenital cataract surgery. [Article in Hebrew] Harefuah 1994 Jun 1;126(11):645-7, 691.
4. Svacova H, et al. Retinal detachment in pseudophakia. [Article in Slovak] Cesk Oftalmol 1991 Mar;47(2):98-104.
5. Marty N, et al. Epidemiology of nosocomial infections after cataract surgery and role of the Infection Control Committee in prevention. [Article in French] Bull Acad Natl Med 2002;186(3):635-45; discussion 645-8.
6. Carlson AN, et al. Infectious complications of modern cataract surgery and intraocular lens implantation. Infect Dis Clin North Am 1989 Jun;3(2):339-55.
7. Chercota V. Corneal edema, a complication of cataract surgery. [Article in Romanian] Oftalmologia 1995 Oct-Dec;39(4):343-8.
8. Lumme P, et al. Risk factors for intraoperative and early postoperative complications in extracapsular cataract surgery. Eur J Ophthalmol 1994 Jul-Sep;4(3):151-8.
9. Obuchowska I, et al. The evaluation of incidence of massive suprachoroidal hemorrhage in the material of the Department of Ophthalmology, Medical Academy in Bialystok from 1990 to 2000. [Article in Polish] Klin Oczna 2002;104(2):93-5.
10. Jacques PF, et al. Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol 2001 Jul; 119(7):1009-19.
11. Cumming RG, et al. Diet and cataract: the Blue Mountains Eye Study. Ophthalmology 2000 Mar; 107(3):450-6.
12. Babizhayev MA, et al. Lipid peroxide and reactive oxygen species generating systems of the crystalline lens. Biochim Biophys Acta 1994 Feb 22; 1225(3):326-37.
13. Wang AM, et al. Use of carnosine as a natural anti-senescence drug for human beings. Biochemistry (Mosc) 2000 Jul; 65(7):869-71.
14. Quinn PJ, et al. Carnosine: its properties, functions and potential therapeutic applications. Mol Aspects Med 1992; 13(5):379-444.
15. Specht S, et al. Continuing damage to rat retinal DNA during darkness following light exposure. Photochem Photobiol 2000; 71(5):559-66.
16. Lou MF. Thiol regulation in the lens. J Ocul Pharmacol Ther 2000 Apr; 16(2):137-48.
17. Wang AM, et al. Use of carnosine as a natural anti-senescence drug for human beings. Department of Biochemistry and Department of Neurobiology, Harbin Medical University, China 1999.
18. Babizhayev M, et al. Efficacy of N-acetylcarnosine in the treatment of cataracts. Drugs Research & Development 2002; 3(2):87-103.
19. Giblin FJ. Glutathione: a vital lens antioxidant. J Ocul Pharmacol Ther 2000 Apr; 16(2):121-35.
20. Kamei A. Glutathione levels of the human crystalline lens in aging and its antioxidant effect against the oxidation of lens proteins. Biol Pharm Bull 1993; 16(9); 170-5.
21. Devamanorharan PS, et al. Oxidative stress to rat lens in vitro: protection by taurine. Free Radic Res 1998 Sep; 29(3): 189-95.
22. Hockwin O. The medical treatment of senile cataract in man: a controlled clinical study on the efficacy of a preparation. Institute for Experimental Ophthalmology, Bonn University, Fed Republic of Germany, Oct 2, 1978 to July 8, 1980.
23. Hockwin O, Ophthalmic Research, 1978, 10 (5-6): 250-8.
24. Oguchi M, et al. Glutathione and eye diseases. Ganka, 1970; 12: 125-32.
25. Fujii S, et al. Effects of an eye drop solution, tathion, on cataract. Nippon Ganka Kiyo 1968; 19:136-42.
26. Kandori F, et al. Clinical use of topical glutathione for cataract. Nippon Ganka Gakkai Zasshi 1967; 71: 689-97.
27. Mitton KP, et al. Modelling cortical cataractogenesis 21: in diabetic rat lenses taurine supplementation partially reduces damage resulting from osmotic compensation leading to osmolyte loss and antioxidant depletion. Exp Eye Res 1999 Sep; 69(3): 279-89.
28. Killic F, et al. Modelling cortical cataractogenesis 22: is in vitro reduction of damage in model diabetic rat cataract by taurine due to its antioxidant activity? Exp Eye Res 1999 Sep; 69(3):291-300.]
29. Devamanoharan PS, et al. Oxidative stress to rat lens in vitro: protection by taurine. Free Radic Res 1998 Sep;29(3):189-95.
30. Brubaker RF, et al. Ascorbic acid content of human corneal epithelium. Invest Ophthalmol Vis Sci 2000 Jun;41(7):1681-3
31. Hankinson SE, et al. Nutrient intake and cataract extraction in women: a prospective study. BMJ 1992 Aug 8;305(6849):335-9
32. Mares-Perlman JA, et al. Vitamin supplement use and incident cataracts in a population-based study. Arch Ophthalmol 2000 Nov;118(11):1556-63.
33. Robertson JMcD. A possible role for vitamins C and E in cataract prevention. Am J Clin Nutr 1991; 53:346S-351S.
34. Taylor A, et al. Long-term intake of vitamins and carotenoids and odds of early age-related cortical and posterior subcapsular lens opacities. Am J Clin Nutr 2002 Mar;75(3):540-9.
35. News from the AAO: New Study Indicates Nutrition May Play Greater Role in Preventing Cataracts. press release from the American Academy of Ophthalmology, March 10, 2000.
36. Kuzniarz M, et al. Use of vitamin supplements and cataract: the Blue Mountains Eye Study. Am J Ophthalmol 2001 Jul;132(1):19-26.
37. Detcho A, et al. Endogenous ascorbate regenerates vitamin E in the retina directly and in combination with exogenous dihydrolipoic acid. Curr Eye Res 1994; 181-9.
38. Robertson JMcD, et al. Vitamin E intake and risk of cataract in humans. Ann NY Acad Sci 1993; 372-82.
39. Olmedilla B, et al. Serum status of carotenoids and tocopherols in patients with age-related cataracts: a case-control study. J Nutr Health Aging 2002;6(1):66-8.
40. Campisi A, et al. Antioxidant systems in rat lens as a function of age: effect of chronic administration of vitamin E and ascorbate. Aging (Milano) 1999 Feb; 11(1):39-43.
41. Ayalasomayajula SP, et al. Induction of vascular endothelial growth factor by 4-hydroxynonenal and its prevention by glutathione precursors in retinal pigment epithelial cells. Eur J Pharmacol 2002 Aug 9;449(3):213-20.
42. Seddon JM, et al. Dietary carotenoids, vitamins A, C and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994 Nov 9;272(18):1413-20.
43. Delcourt C, et al. Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group, Pathologies Oculaires Liees a l'Age. Arch Ophthalmol 1999 Oct;117(10):1384-90.
44. Wegener A, et al. Experimental evidence for interactive effects of chronic UV irradiation and nutritional deficiencies in the lens. Dev Ophthalmol 2002; 35:113-24.
45. Popova ZS, et al. Treatment of primary open-angle glaucoma by the method of combimed use of hyperbaric oxygenation and antioxidants. Vestn Oftalmol 1996 Jan-Mar;112(1):4-6.
46. Smith, Wayne, et al. Dietary fat and fish intake and age-related maculopathy. Archives of Ophthalmology, Vol. 118, March 2000, pp. 401-04
47. Johanna M. Seddon; Gary Gensler; Roy C. Milton; Michael L. Klein; Nader Rifai. Association Between C-Reactive Protein and Age-Related Macular Degeneration. JAMA. 2004;291:704-710.
48. Cho, Eunyoung, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. American Journal of Clinical Nutrition 2001;73:209-218.
49. Chibret H. Dry eyes syndrome: reality and perspectives of treatment. Ann Pharm Fr 2002 Mar; 60(2):115-22.
50. Hammond BR, Jr., Johnson EJ, Russell RM, et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci. 1997 Aug: 38(9): 1795-801.
51. Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE. A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res. 1997 Jul;65(1):57-62.
52. Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Noren D. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3322-6.
53. Koh HH, Murray IJ, Nolan D, Carden D, Feather J, Beatty S. Plasma and macular responses to lutein supplementation in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res. 2004 Jul;79(1):21-7.
54. Trivedi KA. Omega-3 fatty acids reduce risk of dry eye syndrome. ARVO 2003 Annual Meeting: abstract 2112, presented May 6, 2003.
Adapted with permission from an article in Life Extension, Feb 2003